Ticker · CUSIP 18914F103
Holders (tracked)
8
Combined shares
8,339,069
Combined value
$19.60M
Last close
$2.19
Quarter
2025Q4
Price · 1Y$2.19-1.41 (-39.17%)H $3.82 · L $1.70 · Avg Vol 7.3M
Position opened
Tracked holders · last 8 quarters
Flat over the last 8 quarters.
Price is -6.8% vs the avg quarter-end implied price across tracked holders.
SEC event timeline
13 events
- Ken Griffin (Citadel Advisors) trimmed2026-02-17−339,710 shares · 2025Q4Position
- D.E. Shaw & Co. trimmed2026-02-17−118,218 shares · 2025Q4Position
- Izzy Englander (Millennium Mgmt) exited2026-02-17−231,166 shares · 2025Q4Position
- T. Rowe Price trimmed2026-02-17−33,305 shares · 2025Q4Position
- +194,880 shares · 2025Q4Position
- AQR Capital Management trimmed2026-02-17−29,936 shares · 2025Q4Position
- Renaissance Technologies trimmed2026-02-12−3,221,559 shares · 2025Q4Position
- −610,619 shares · 2025Q3Position
- AQR Capital Management added2025-11-14+28,476 shares · 2025Q3Position
- D.E. Shaw & Co. added2025-11-14+353,949 shares · 2025Q3Position
- Izzy Englander (Millennium Mgmt) trimmed2025-11-14−827,049 shares · 2025Q3Position
- T. Rowe Price added2025-11-14+18,570 shares · 2025Q3Position
- Renaissance Technologies trimmed2025-11-13−2,780,900 shares · 2025Q3Position
Insider activity
Last 30 days
Net (open-market)
$0
Buys
0 · $0
Sells
0 · $0
Unique insiders
6
| Date | Insider | Code | Shares | Price | Value |
|---|---|---|---|---|---|
| 04-15 | Toy Andrew Chief Executive Officer · Officer, Director | F | 60,765 | $2.04 | $124.0K |
| 04-15 | Wai Conrad CEO, Counterpart Health · Officer | F | 23,463 | $2.04 | $47.9K |
| 04-15 | Soares Karen Chief Legal Officer · Officer | F | 10,161 | $2.04 | $20.7K |
| 04-15 | Priest Brady Patrick CEO of Clover Care Services · Officer | F | 15,471 | $2.04 | $31.6K |
| 04-15 | Reynoso Jamie L. CEO, Medicare Advantage · Officer | F | 12,712 | $2.04 | $25.9K |
| 04-15 | THORNTON JOSEPH CLAY Interim CFO · Officer | F | 4,158 | $2.04 | $8.5K |
Follow-the-investor returns
If you'd copied each holder of CLOV…
Cost basis inferred from each manager's quarter-over-quarter position changes. Sorted by % return on the position they're still holding.
| Investor | First in | Cost basis | Return | Position value today |
|---|---|---|---|---|
| Renaissance Technologies | 2022Q1 | $1.48 | +47.8% | $9.8M |
| AQR Capital Management | 2022Q4 | $2.42 | -9.4% | $36K |
| Ken Griffin (Citadel Advisors) | 2021Q2 | $2.90 | -24.6% | $1.2M |
| Ken Griffin (Citadel Advisors) | 2021Q2 | $2.90 | -24.6% | $1.2M |
| Ken Griffin (Citadel Advisors) | 2021Q2 | $2.90 | -24.6% | $1.2M |
| Paul Tudor Jones (Tudor Investment) | 2021Q2 | $2.93 | -25.1% | $427K |
| T. Rowe Price | 2021Q3 | $3.00 | -27.1% | $735K |
| D.E. Shaw & Co. | 2021Q2 | $3.05 | -28.3% | $619K |
Who moved on this name in 2025Q4
Position changes reported for the latest quarter, grouped by direction.
New positions1
- Paul Tudor Jones (Tudor Investment)+194,880$458K
Added to0
—
Trimmed5
- Renaissance Technologies−3,221,559$7.6M
- Ken Griffin (Citadel Advisors)−339,710$798K
- D.E. Shaw & Co.−118,218$278K
- AQR Capital Management−29,936$70K
- T. Rowe Price−33,305$78
Exited1
- Izzy Englander (Millennium Mgmt)−231,166$707K
Institutional ownership over time
Distinct super-investors holding this ticker · combined dollar value, by quarter.
| Quarter | Holders | Combined value |
|---|---|---|
| 2022Q1 | 12 | $95.7M |
| 2022Q2 | 10 | $72.2M |
| 2022Q3 | 9 | $62.2M |
| 2022Q4 | 11 | $37.5M |
| 2023Q1 | 8 | $31.1M |
| 2023Q2 | 10 | $24.9M |
| 2023Q3 | 9 | $32.4M |
| 2023Q4 | 8 | $26.5M |
| 2024Q1 | 8 | $21.3M |
| 2024Q2 | 8 | $31.7M |
| 2024Q3 | 8 | $51.1M |
| 2024Q4 | 7 | $48.8M |
| 2025Q1 | 8 | $74.4M |
| 2025Q2 | 9 | $50.0M |
| 2025Q3 | 8 | $38.0M |
| 2025Q4 | 8 | $19.6M |
Who owns CLOV
8 super-investors · 2025Q4
Tracked stake
8.34M
shares
Combined value
$20M
% of shares outstanding
—
shares-out unknown
Quarter action mix
New1Trim7
| # | Manager | Shares | Value |
|---|---|---|---|
| 1 | Renaissance Technologies | 4.49M | $11M |
| 2 | Ken Griffin Citadel Advisors | 1.31M | $3M |
| 3 | Ken Griffin Citadel Advisors | 1.15M | $3M |
| 4 | Ken Griffin Citadel Advisors | 557.6K | $1M |
| 5 | T. Rowe Price | 335.5K | $789K |
| 6 | D.E. Shaw & Co. | 282.7K | $664K |
| 7 | Paul Tudor Jones Tudor Investment | 194.9K | $458K |
| 8 | AQR Capital Management | 16.3K | $38K |
Recent moves
20 transactions
- TRIMD.E. Shaw & Co.−118,218 · 2025Q4
- −29,936 · 2025Q4
- +194,880 · 2025Q4
- −231,166 · 2025Q4
- −339,710 · 2025Q4
- TRIMT. Rowe Price−33,305 · 2025Q4
- −3,221,559 · 2025Q4
- −610,619 · 2025Q3
- +18,570 · 2025Q3
- −827,049 · 2025Q3
- +28,476 · 2025Q3
- +353,949 · 2025Q3
- −2,780,900 · 2025Q3
- +197,759 · 2025Q2
- −4,745,791 · 2025Q2
- +117,894 · 2025Q2
- +46,959 · 2025Q2
- +4,178 · 2025Q2
- −530,800 · 2025Q2
- −237,200 · 2025Q1
Embed this chart
Paste this iframe anywhere to embed the live CLOV chart.
<iframe src="https://openstocks.me/embed/stocks/CLOV" width="100%" height="480" frameborder="0" loading="lazy" title="CLOV chart by OpenStocks" style="border:0;border-radius:12px;background:transparent"></iframe>Explore related topics
- CLOV insider tradingEvery Form 4 filing by CLOV officers, directors, and 10%+ holders.
- CLOV analyst target pricesWall Street consensus target, analyst-by-analyst breakdown, and revision history.
- Most popular hedge-fund stocksSee where this ticker ranks against the broader smart-money consensus.
- All insider tradingCross-ticker view of where corporate insiders are buying on the open market.
- Congress stock tradesReal-time PTR disclosures filed under the STOCK Act.
- Smart-money signalsComposite signals where institutional, insider and Congress flows converge.